Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Not Yet Recruiting

A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

NCT06659770

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT06655519

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma

NCT06594211

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

NCT06500507

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Bleeding in Multiple Myeloma

NCT06482931

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

NCT06472479

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Anhui Cancer Hospital Hefei, Anhui, China

Henan Cancer Hospital Zhengzhou, Henan, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

Beijing Gobroad Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant

NCT05982275

Conditions: Allogeneic Stem Cell Transplantation, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations: Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain

Hospital Santa Creu i Sant Pau Barcelona, Spain

Complejo asistencial universitario de Salamanca Salamanca, Spain

José Antonio Pérez Simón Seville, Spain

View Trial Details

Not Yet Recruiting

A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.

NCT06369935

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Study of SYS6020 in BCMA-positive Multiple Myeloma

NCT06359509

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

NCT06333509

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Not specified

View Trial Details